Researchers at the University of Louisville School of Medicine are using breath analysis to detect the presence of lung cancer.
Preliminary data indicate that this promising noninvasive tool offers the sensitivity of PET scanning, and has almost twice the specificity of PET for distinguishing patients with benign lung disease from those with early stage cancer. Michael Bousamra II, MD, Associate Professor, Department of Cardiovascular and Thoracic Surgery, is presenting the results of the study at the AATS 2014 Conference on April 29, 2014.
A reliable, noninvasive diagnostic method imposes less physical and financial burden on patients who actually have no significant disease, while rapid and accurate diagnosis expedites treatment for patients who truly have lung cancer.
The team believes that while the breath test would not replace CT as a primary screening tool, it would be particularly helpful in conjunction with a positive CT scan result. “This breath analysis method presents the potential for a cheaper and more reliable diagnostic option for patients found to have bulky disease on a CT scan. If the breath analysis is negative, the patient may, in some instances, be followed with repeated exams without necessitating a biopsy. But a positive breath analysis would indicate that the patient may proceed to definitive biopsy, thus expediting treatment,” says Dr. Bousamra.
Investigators used specially coated silicon microchips to collect breath samples from 88 healthy controls, 107 patients with lung cancer, 40 individuals with benign pulmonary disease, and 7 with metastatic lung cancer.
Previous work had pinpointed four specific substances, known as carbonyl compounds, in breath samples as “elevated cancer markers” (ECMs) that distinguish patients with lung cancer from those with benign disease. The carbonyl compounds found in the breath are thought to reflect chemical reactions occurring in malignant lung tumors. In this study, the authors compared the findings from the breath analyses to the results from PET scans.
The investigators found that the sensitivity and specificity of breath analysis depended upon how many of the ECMs were elevated. For example, having 3 or 4 ECMs was diagnostic of lung cancer in 95% of those with this result. The majority of patients with benign pulmonary disease had either 0 or 1 ECM, while those with Stage IV cancer were most likely to have 3 or 4. The number of ECMs could be used to differentiate benign disease from both early and advanced stage lung cancer. Interestingly, 3 of the 4 elevated markers returned to normal levels after cancer resection.
When it comes to differentiating early stage lung cancer from benign pulmonary disease, breath analysis and PET scanning had similar sensitivities (82.8% and 90.3%, respectively). However, breath analysis had a much higher specificity than PET (75% vs. 38.7%, respectively) for distinguishing benign disease, which means that it was much more accurate at identifying those who did not have cancer. This would be an important feature for patients with benign disease, since having a breath analysis rather than PET scan could mean avoiding an unnecessary invasive biopsy procedure later on.
The Latest on: Detect Early Lung Cancer
via Google News
The Latest on: Detect Early Lung Cancer
- Aspirus shares information on lung canceron August 2, 2022 at 7:06 am
Lung cancer is commonly associated with people who smoke, but the reality is not everyone who smokes gets cancer,” Aspirus said. “According to the American Cancer Society, lung cancer is the second ...
- Early detection of lung cancer can help save lives, health experts sayon August 1, 2022 at 7:40 pm
Lung cancer is the leading cause of cancer deaths in the country. According to the American Cancer Society, More than 236,000 Americans will be diagnosed with lung cancer this year, and more than half ...
- Early detection screening awareness focus of World Lung Cancer Dayon August 1, 2022 at 5:08 pm
A new American Lung Association Survey shows nearly 70% of Americans are not aware of early detection lung cancer screening for people at high risk.
- American Lung Association urges early detection lung cancer screenings for people at high riskon August 1, 2022 at 3:47 pm
A new American Lung Association survey shows nearly 70 percent of Americans are not aware of early detection lung cancer screening for people at high risk. Guidelines from the U.S. Preventive Services ...
- Medical Minute: World Lung Cancer Dayon August 1, 2022 at 3:13 pm
Monday, August 1 is World Lung Cancer Day, a day to raise awareness about the leading cause of cancer deaths in the U.S., according to the American Lung Association.
- World Lung Cancer Day: a call to actionon August 1, 2022 at 12:30 pm
Monday, August 1, is World Lung Cancer Day, a day to raise awareness about the leading cause of cancer deaths in the U.S., according to the American Lung Association.
- Advancements in detection, diagnosis helping increase lung cancer survival rateson August 1, 2022 at 7:12 am
World Lung Cancer Day reminds us of the importance of screenings for at-risk patientsCENTER VALLEY, Pa., Aug. 1, 2022 /PRNewswire/ -- World Lung ...
- Survey: 70% of Americans are not aware of early detection lung cancer screeningon August 1, 2022 at 6:58 am
Aug. 1 is World Lung Cancer Day, a day to raise awareness about the leading cause of cancer deaths in the U.S.
- Early lung cancer detectionon August 1, 2022 at 4:15 am
Lung Cancer is commonly associated with people who smoke, but the reality is not everyone who smokes gets cancer. August 1 is World Lung Cancer Day. According to the American Cancer Society, lung ...
- Lung Cancer Remains the Leading Cause of Cancer Deaths in the U.S.on August 1, 2022 at 2:49 am
The American Lung Association has released its annual Lung Health Barometer survey. Overall, the pace of lung cancer deaths is down, but it remains stubbornly high. While smoking remains the number ...
via Bing News